Haoxi Health Technology Limited (HAO) 10-Year Financial Performance & Capital Metrics

HAO • • Industrial / General

Communication ServicesAdvertising & MarketingSpecialized Digital Marketing ServicesPerformance Marketing Specialists

AboutHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.Show more

Revenue $49M +71.9%
EBITDA $2M +43.5%
Net Income $1M +33.2%
EPS (Diluted) 1.06 +1104.5%
Gross Margin 5.67% -22.4%
EBITDA Margin 3.56% -16.5%
Operating Margin 3.54% -16.4%
Net Margin 2.66% -22.5%
ROE 20.12% -99.0%
ROIC 36.64% -50.4%
Debt/Equity 0.11 -80.4%
Interest Coverage 41.69 -27.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 971.9%
✓Momentum leader: RS Rating 86 (top 14%)
✓Efficient asset utilization: 3.1x turnover

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Shares diluted 10.8% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y55.73%

TTM188.38%

Profit (Net Income) CAGR

10Y-

5Y-

3Y61.96%

TTM87.3%

EPS CAGR

10Y-

5Y-

3Y228.14%

TTM101.54%

ROCE

10Y Avg296.04%

5Y Avg296.04%

3Y Avg296.04%

Latest25.39%

Peer Comparison

Performance Marketing Specialists

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
QNSTQuinStreet, Inc.	828.01M	14.59	180.79	78.27%	0.96%	4.3%	10.01%	0.04
XNETXunlei Limited	470.86M	7.66	80.63	-11.16%	315.31%	79.34%	4.81%	0.09
SDMSmart Digital Group Limited Ordinary Shares	49.44M	1.85	28.91	121.8%	7.88%	30.89%		0.05
TZOOTravelzoo	66.47M	6.08	5.74	-0.68%	8.83%	180.99%	31.48%	1.86
HAOHaoxi Health Technology Limited	20.63M	1.50	1.42	71.88%	1.73%	8.43%		0.11
STFSStar Fashion Culture Holdings Limited	5.43M	0.12	0.13	57.6%	1.52%	0.51%	100%	0.24
BAOSBaosheng Media Group Holdings Limited	4.36M	2.84	-0.16	-32.3%	-18.58%	-193.72%		0.05
TNMGTNL Mediagene	97.49M	2.36	-0.68	35.31%	-175.29%	-156.3%		0.64

Profit & Loss

	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Sales/Revenue+	12.85M	16.16M	28.23M	48.52M
Revenue Growth %	-	0.26%	0.75%	0.72%
Cost of Goods Sold+	12.24M	15.51M	26.17M	45.77M
COGS % of Revenue	0.95%	0.96%	0.93%	0.94%
Gross Profit+	605.58K	648.72K	2.06M	2.75M
Gross Margin %	0.05%	0.04%	0.07%	0.06%
Gross Profit Growth %	-	0.07%	2.18%	0.33%
Operating Expenses+	275.02K	379.95K	866.25K	1.03M
OpEx % of Revenue	0.02%	0.02%	0.03%	0.02%
Selling, General & Admin	212.38K	277.43K	808.09K	953.14K
SG&A % of Revenue	0.02%	0.02%	0.03%	0.02%
Research & Development	62.65K	102.52K	58.16K	79.98K
R&D % of Revenue	0%	0.01%	0%	0%
Other Operating Expenses	0	0	0	0
Operating Income+	330.55K	268.77K	1.2M	1.72M
Operating Margin %	0.03%	0.02%	0.04%	0.04%
Operating Income Growth %	-	-0.19%	3.45%	0.44%
EBITDA+	330.96K	270.98K	1.2M	1.73M
EBITDA Margin %	0.03%	0.02%	0.04%	0.04%
EBITDA Growth %	-	-0.18%	3.44%	0.43%
D&A (Non-Cash Add-back)	411	2.21K	8.39K	10.57K
EBIT	330.55K	269.56K	1.21M	1.78M
Net Interest Income+	-5.27K	-9.96K	-20.9K	34.91K
Interest Income	0	0	0	76.1K
Interest Expense	5.27K	9.96K	20.9K	41.19K
Other Income/Expense	-5.27K	-9.17K	-5.41K	18K
Pretax Income+	325.28K	259.6K	1.19M	1.74M
Pretax Margin %	0.03%	0.02%	0.04%	0.04%
Income Tax+	21.22K	15.01K	220.65K	443.58K
Effective Tax Rate %	0.93%	0.94%	0.81%	0.74%
Net Income+	304.06K	244.59K	969.75K	1.29M
Net Margin %	0.02%	0.02%	0.03%	0.03%
Net Income Growth %	-	-0.2%	2.96%	0.33%
Net Income (Continuing)	304.06K	244.59K	969.75K	1.29M
Discontinued Operations	0	0	0	0
Minority Interest	0	0	0	0
EPS (Diluted)+	0.03	0.02	0.09	1.06
EPS Growth %	-	-0.2%	2.67%	11.05%
EPS (Basic)	0.03	0.02	0.09	1.06
Diluted Shares Outstanding	10M	10M	11.05M	12.24M
Basic Shares Outstanding	10M	10M	11.05M	12.24M
Dividend Payout Ratio	-	-	-	-

Balance Sheet

	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Total Current Assets+	2.63M	445.06K	3.67M	15.38M
Cash & Short-Term Investments	55.89K	293.51K	1.2M	6.66M
Cash Only	55.89K	293.51K	1.2M	6.66M
Short-Term Investments	0	0	0	0
Accounts Receivable	1.97M	3.92K	66.22K	3.55M
Days Sales Outstanding	56.01	0.09	0.86	26.7
Inventory	471.46K	0	2.4M	5.17M
Days Inventory Outstanding	14.06	-	33.54	41.26
Other Current Assets	-342.24K	0	0	-5.17M
Total Non-Current Assets+	185.63K	97.94K	790.13K	126.74K
Property, Plant & Equipment	185.63K	97.94K	233.38K	126.74K
Fixed Asset Turnover	69.21x	164.97x	120.96x	382.82x
Goodwill	0	0	0	0
Intangible Assets	0	0	0	0
Long-Term Investments	0	0	0	0
Other Non-Current Assets	0	0	556.75K	0
Total Assets+	2.81M	542.99K	4.46M	15.51M
Asset Turnover	4.57x	29.76x	6.32x	3.13x
Asset Growth %	-	-0.81%	7.22%	2.47%
Total Current Liabilities+	4.68M	2.01M	2.58M	3.87M
Accounts Payable	2.92M	1.27M	27.34K	653.69K
Days Payables Outstanding	87.19	29.93	0.38	5.21
Short-Term Debt	178.82K	439.4K	511.41K	833.52K
Deferred Revenue (Current)	542.44K	166.9K	1000K	1000K
Other Current Liabilities	880.29K	0	0	102.44K
Current Ratio	0.56x	0.22x	1.43x	3.98x
Quick Ratio	0.46x	0.22x	0.49x	2.64x
Cash Conversion Cycle	-17.13	-	34.02	62.75
Total Non-Current Liabilities+	68.56K	0	321.21K	368.04K
Long-Term Debt	0	0	249.11K	368.04K
Capital Lease Obligations	68.56K	0	0	0
Deferred Tax Liabilities	0	0	0	0
Other Non-Current Liabilities	0	0	72.1K	0
Total Liabilities	4.74M	2.01M	2.9M	4.23M
Total Debt+	335.03K	505.4K	850.06K	1.2M
Net Debt	1.09M	211.89K	-353.14K	-5.45M
Debt / Equity	-	-	0.54x	0.11x
Debt / EBITDA	1.01x	1.87x	0.71x	0.70x
Net Debt / EBITDA	3.29x	0.78x	-0.29x	-3.16x
Interest Coverage	62.72x	26.98x	57.21x	41.69x
Total Equity+	-1.93M	-1.47M	1.57M	11.27M
Equity Growth %	-	0.24%	2.07%	6.2%
Book Value per Share	-0.19	-0.15	0.14	0.92
Total Shareholders' Equity	-1.93M	-1.47M	1.57M	11.27M
Common Stock	2.54K	2.54K	2.95K	3.22K
Retained Earnings	-1.78M	-1.54M	-568.46K	723.21K
Treasury Stock	0	0	0	0
Accumulated OCI	-176K	-112.96K	-44.78K	-44.39K
Minority Interest	0	0	0	0

Cash Flow

	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Cash from Operations+	2.65M	-675.36K	-872.13K	-747.58K
Operating CF Margin %	0.21%	-0.04%	-0.03%	-0.02%
Operating CF Growth %	-	-1.25%	-0.29%	0.14%
Net Income	304.06K	244.59K	969.75K	1.29M
Depreciation & Amortization	411	2.21K	8.39K	10.57K
Stock-Based Compensation	0	0	0	0
Deferred Taxes	0	0	0	0
Other Non-Cash Items	3.36M	-1.63M	0	0
Working Capital Changes	-1.02M	710.99K	-1.85M	-2.05M
Change in Receivables	-295.26K	665.62K	-4.28K	-217.9K
Change in Inventory	0	0	0	0
Change in Payables	0	0	-1.2M	623.17K
Cash from Investing+	-3.26K	-8.7K	-45.5K	-3.13M
Capital Expenditures	-3.26K	-8.7K	-45.5K	-55.37K
CapEx % of Revenue	0%	0%	0%	0%
Acquisitions	-	-	-	-
Investments	-	-	-	-
Other Investing	0	0	0	-3.07M
Cash from Financing+	-2.61M	933.22K	1.8M	9.32M
Debt Issued (Net)	-	-	-	-
Equity Issued (Net)	-	-	-	-
Dividends Paid	0	0	0	0
Share Repurchases	-	-	-	-
Other Financing	-1.27M	0	-558.52K	-14.33K
Net Change in Cash	-	-	-	-
Free Cash Flow+	2.65M	-684.06K	-917.63K	-802.94K
FCF Margin %	0.21%	-0.04%	-0.03%	-0.02%
FCF Growth %	-	-1.26%	-0.34%	0.12%
FCF per Share	0.26	-0.07	-0.08	-0.07
FCF Conversion (FCF/Net Income)	8.71x	-2.76x	-0.90x	-0.58x
Interest Paid	8.18K	206	0	37.27K
Taxes Paid	1.78K	7.39K	0	27.57K

Key Ratios

Metric	2021	2022	2023	2024
Return on Equity (ROE)	-	-	1923.73%	20.12%
Return on Invested Capital (ROIC)	-	-	73.92%	36.64%
Gross Margin	4.71%	4.02%	7.3%	5.67%
Net Margin	2.37%	1.51%	3.44%	2.66%
Debt / Equity	-	-	0.54x	0.11x
Interest Coverage	62.72x	26.98x	57.21x	41.69x
FCF Conversion	8.71x	-2.76x	-0.90x	-0.58x
Revenue Growth	-	25.76%	74.72%	71.88%

Frequently Asked Questions

Valuation & Price

Haoxi Health Technology Limited (HAO) has a price-to-earnings (P/E) ratio of 1.4x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Haoxi Health Technology Limited (HAO) reported $91.5M in revenue for fiscal year 2024. This represents a 613% increase from $12.8M in 2021.

Haoxi Health Technology Limited (HAO) grew revenue by 71.9% over the past year. This is strong growth.

Yes, Haoxi Health Technology Limited (HAO) is profitable, generating $1.6M in net income for fiscal year 2024 (2.7% net margin).

Dividend & Returns

Haoxi Health Technology Limited (HAO) has a return on equity (ROE) of 20.1%. This is excellent, indicating efficient use of shareholder capital.

Haoxi Health Technology Limited (HAO) had negative free cash flow of $4.2M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener